Search research articles
Contact Us
Filters
Showing results (531-540 of 685) with videos related to
Page
of 69
Sort By:
Phytotherapy Research : PTR
|
October 30, 2024
Co-Micronized Palmitoylethanolamide and Rutin Associated With Hydroxytyrosol Recover Diabesity-Induced Hepatic Dysfunction in Mice: In Vitro Insights Into the Synergistic Effect
S Melini, C Pirozzi, A Lama, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer
M Cantore, G Fiorentini, G Luppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 24, 2001
A teaching videotape for the assessment of essential tremor
E D Louis, L Barnes, K J Wendt, et al.
Journal of Cell Science
|
February 21, 2013
A pathway involving HDAC5, cFLIP and caspases regulates expression of the splicing regulator polypyrimidine tract binding protein in the heart
Junmei Ye, Miriam Llorian, Maria Cardona, et al.
Parkinsonism & Related Disorders
|
April 5, 2025
A validation study of the Clinician's Tardive Inventory (CTI)
Richard M Trosch, Alicia C Shillington, Cynthia L Comella, et al.
Cell Death & Disease
|
February 16, 2013
TNFα induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway
F Marques-Fernandez, L Planells-Ferrer, R Gozzelino, et al.
Melanoma Research
|
December 22, 1999
Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon alpha2a and tamoxifen in metastatic melanoma. BREMIM (Biological Response Modifiers in Melanoma)
M R Sertoli, P Queirolo, E Bajetta, et al.
BMC Cancer
|
November 17, 2006
Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
Giuseppe Palmieri, Sabrina M R Satriano, Mario Budroni, et al.
Cell Death & Disease
|
April 29, 2011
Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12
N Badiola, C Penas, A Miñano-Molina, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 24, 2009
Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer: a randomized phase II SICOG trial
Pasquale Comella, Vincenzo E Chiuri, Giuseppe De Cataldis, et al.
Page
of 69
Search research articles
Search
Showing results (531-540 of 685) with videos related to
Sort By:
Page
of 69
Phytotherapy Research : PTR
|
October 30, 2024
Co-Micronized Palmitoylethanolamide and Rutin Associated With Hydroxytyrosol Recover Diabesity-Induced Hepatic Dysfunction in Mice: In Vitro Insights Into the Synergistic Effect
S Melini, C Pirozzi, A Lama, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer
M Cantore, G Fiorentini, G Luppi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 24, 2001
A teaching videotape for the assessment of essential tremor
E D Louis, L Barnes, K J Wendt, et al.
Journal of Cell Science
|
February 21, 2013
A pathway involving HDAC5, cFLIP and caspases regulates expression of the splicing regulator polypyrimidine tract binding protein in the heart
Junmei Ye, Miriam Llorian, Maria Cardona, et al.
Parkinsonism & Related Disorders
|
April 5, 2025
A validation study of the Clinician's Tardive Inventory (CTI)
Richard M Trosch, Alicia C Shillington, Cynthia L Comella, et al.
Cell Death & Disease
|
February 16, 2013
TNFα induces survival through the FLIP-L-dependent activation of the MAPK/ERK pathway
F Marques-Fernandez, L Planells-Ferrer, R Gozzelino, et al.
Melanoma Research
|
December 22, 1999
Multi-institutional phase II randomized trial of integrated therapy with cisplatin, dacarbazine, vindesine, subcutaneous interleukin-2, interferon alpha2a and tamoxifen in metastatic melanoma. BREMIM (Biological Response Modifiers in Melanoma)
M R Sertoli, P Queirolo, E Bajetta, et al.
BMC Cancer
|
November 17, 2006
Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
Giuseppe Palmieri, Sabrina M R Satriano, Mario Budroni, et al.
Cell Death & Disease
|
April 29, 2011
Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12
N Badiola, C Penas, A Miñano-Molina, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 24, 2009
Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer: a randomized phase II SICOG trial
Pasquale Comella, Vincenzo E Chiuri, Giuseppe De Cataldis, et al.
Page
of 69